Emcure Pharma plans to launch $400-500 million IPO in 2024, hires Kotak. September 26, 2023 1 mins read
Nirma buys 75% stakes In Glenmark Life Sciences to make Glenmark Pharma debt-free September 24, 2023 57 secs read
Lupin, Cipla and Aurobindo: Axis Securities advises to buy these 3 pharma firms after Q1 earnings – key reasons August 30, 2023 40 secs read
